Literature DB >> 27940068

Drug decriminalization and the price of illicit drugs.

Sónia Félix1, Pedro Portugal2.   

Abstract

BACKGROUND: This study is an empirical assessment of the impact of the drug decriminalization policy followed by Portugal in July 2001, on the price of illicit drugs.
METHODS: The analysis is performed using a difference-in-differences approach and the Synthetic Control Method in order to construct a synthetic control unit from a convex combination of countries.
RESULTS: The results suggest that the prices of opiates and cocaine in the post-treatment period did not decrease in the sequence of the policy change.
CONCLUSION: We conclude that the drug decriminalization policy seems to have caused no harm through lower illicit drugs prices, which would lead to higher drug usage and dependence.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug decriminalization policy; Drug prices; Illicit drugs; Treatment effects

Mesh:

Substances:

Year:  2016        PMID: 27940068     DOI: 10.1016/j.drugpo.2016.10.014

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  4 in total

Review 1.  Opioid use disorder.

Authors:  John Strang; Nora D Volkow; Louisa Degenhardt; Matthew Hickman; Kimberly Johnson; George F Koob; Brandon D L Marshall; Mark Tyndall; Sharon L Walsh
Journal:  Nat Rev Dis Primers       Date:  2020-01-09       Impact factor: 52.329

2.  On the biopolitics of humane drug policies: What can we learn from 19th century sobriety boards?

Authors:  Kenneth Arctander Johansen; Michel Vandenbroeck; Stijn Vandevelde
Journal:  Nordisk Alkohol Nark       Date:  2021-05-20

3.  Impact evaluations of drug decriminalisation and legal regulation on drug use, health and social harms: a systematic review.

Authors:  Ayden I Scheim; Nazlee Maghsoudi; Zack Marshall; Siobhan Churchill; Carolyn Ziegler; Dan Werb
Journal:  BMJ Open       Date:  2020-09-21       Impact factor: 2.692

4.  Deaths from novel psychoactive substances in England, Wales and Northern Ireland: Evaluating the impact of the UK psychoactive substances act 2016.

Authors:  Adrian A Deen; Hugh Claridge; Richard D Treble; Hilary J Hamnett; Caroline S Copeland
Journal:  J Psychopharmacol       Date:  2021-06-29       Impact factor: 4.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.